Literature DB >> 15486468

Anti-inflammatory properties of HDL.

Benjamin J Ansell1, Mohamad Navab, Karol E Watson, Gregg C Fonarow, Alan M Fogelman.   

Abstract

Mesh:

Substances:

Year:  2004        PMID: 15486468     DOI: 10.1023/B:REMD.0000045107.71895.b2

Source DB:  PubMed          Journal:  Rev Endocr Metab Disord        ISSN: 1389-9155            Impact factor:   6.514


× No keyword cloud information.
  62 in total

Review 1.  The role of high-density lipoproteins in oxidation and inflammation.

Authors:  B J Van Lenten; M Navab; D Shih; A M Fogelman; A J Lusis
Journal:  Trends Cardiovasc Med       Date:  2001 Apr-May       Impact factor: 6.677

2.  High-density lipoproteins as an emerging therapeutic target for atherosclerosis.

Authors:  Daniel J Rader
Journal:  JAMA       Date:  2003-11-05       Impact factor: 56.272

Review 3.  Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity.

Authors:  D Steinberg; S Parthasarathy; T E Carew; J C Khoo; J L Witztum
Journal:  N Engl J Med       Date:  1989-04-06       Impact factor: 91.245

Review 4.  Role of oxidized low density lipoprotein in atherogenesis.

Authors:  J L Witztum; D Steinberg
Journal:  J Clin Invest       Date:  1991-12       Impact factor: 14.808

Review 5.  The oxidative modification hypothesis of atherosclerosis: does it hold for humans?

Authors:  J L Witztum; D Steinberg
Journal:  Trends Cardiovasc Med       Date:  2001 Apr-May       Impact factor: 6.677

6.  Induction of endothelial cell expression of granulocyte and macrophage colony-stimulating factors by modified low-density lipoproteins.

Authors:  T B Rajavashisth; A Andalibi; M C Territo; J A Berliner; M Navab; A M Fogelman; A J Lusis
Journal:  Nature       Date:  1990-03-15       Impact factor: 49.962

7.  Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response. Loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures.

Authors:  B J Van Lenten; S Y Hama; F C de Beer; D M Stafforini; T M McIntyre; S M Prescott; B N La Du; A M Fogelman; M Navab
Journal:  J Clin Invest       Date:  1995-12       Impact factor: 14.808

8.  Minimally modified low density lipoprotein is biologically active in vivo in mice.

Authors:  F Liao; J A Berliner; M Mehrabian; M Navab; L L Demer; A J Lusis; A M Fogelman
Journal:  J Clin Invest       Date:  1991-06       Impact factor: 14.808

9.  L-4F, an apolipoprotein A-1 mimetic, dramatically improves vasodilation in hypercholesterolemia and sickle cell disease.

Authors:  Jingsong Ou; Zhijun Ou; Deron W Jones; Sandra Holzhauer; Ossama A Hatoum; Allan W Ackerman; Dorothee W Weihrauch; David D Gutterman; Karen Guice; Keith T Oldham; Cheryl A Hillery; Kirkwood A Pritchard
Journal:  Circulation       Date:  2003-05-05       Impact factor: 29.690

10.  Malondialdehyde alteration of low density lipoproteins leads to cholesteryl ester accumulation in human monocyte-macrophages.

Authors:  A M Fogelman; I Shechter; J Seager; M Hokom; J S Child; P A Edwards
Journal:  Proc Natl Acad Sci U S A       Date:  1980-04       Impact factor: 11.205

View more
  11 in total

1.  Liver receptor homolog 1 is a negative regulator of the hepatic acute-phase response.

Authors:  Nicolas Venteclef; Jason C Smith; Bryan Goodwin; Philippe Delerive
Journal:  Mol Cell Biol       Date:  2006-09       Impact factor: 4.272

2.  Tc-99m sestamibi lower extremity muscle scan, is it a useful screening tool for assessment of preclinical atherosclerosis in rheumatoid arthritis patients?

Authors:  Amr M Amin; Zeinab O Nawito; Rania A Atfy; Khaled T El-Hadidi
Journal:  Rheumatol Int       Date:  2011-04-13       Impact factor: 2.631

Review 3.  Why targeting HDL should work as a therapeutic tool, but has not.

Authors:  Mary G Sorci-Thomas; Michael J Thomas
Journal:  J Cardiovasc Pharmacol       Date:  2013-09       Impact factor: 3.105

4.  Cholesteryl ester transfer protein gene haplotypes, plasma high-density lipoprotein levels and the risk of coronary heart disease.

Authors:  Pamela A McCaskie; John P Beilby; Caroline M L Chapman; Joseph Hung; Brendan M McQuillan; Peter L Thompson; Lyle J Palmer
Journal:  Hum Genet       Date:  2007-02-08       Impact factor: 4.132

Review 5.  Lipid peroxidation and decomposition--conflicting roles in plaque vulnerability and stability.

Authors:  Sampath Parthasarathy; Dmitry Litvinov; Krithika Selvarajan; Mahdi Garelnabi
Journal:  Biochim Biophys Acta       Date:  2008-03-25

Review 6.  Lipoprotein carriers of microRNAs.

Authors:  Danielle L Michell; Kasey C Vickers
Journal:  Biochim Biophys Acta       Date:  2016-01-26

7.  Patients with early rheumatoid arthritis exhibit elevated autoantibody titers against mildly oxidized low-density lipoprotein and exhibit decreased activity of the lipoprotein-associated phospholipase A2.

Authors:  Evangelia S Lourida; Athanasios N Georgiadis; Eleni C Papavasiliou; Athanasios I Papathanasiou; Alexandros A Drosos; Alexandros D Tselepis
Journal:  Arthritis Res Ther       Date:  2007       Impact factor: 5.156

8.  Seven functional polymorphisms in the CETP gene and myocardial infarction risk: a meta-analysis and meta-regression.

Authors:  Qi Wang; Shao-Bo Zhou; Li-Jie Wang; Ming-Ming Lei; Yong Wang; Chi Miao; Yuan-Zhe Jin
Journal:  PLoS One       Date:  2014-02-12       Impact factor: 3.240

9.  Elevated expression of phospholipid transfer protein in bone marrow derived cells causes atherosclerosis.

Authors:  Rien van Haperen; Hannelore Samyn; Matthijs Moerland; Teus van Gent; Marian Peeters; Frank Grosveld; Arie van Tol; Rini de Crom
Journal:  PLoS One       Date:  2008-05-28       Impact factor: 3.240

Review 10.  Atherogenic lipid profiles and its management in patients with rheumatoid arthritis.

Authors:  Michael T Nurmohamed
Journal:  Vasc Health Risk Manag       Date:  2007
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.